Trials / Completed
CompletedNCT06341127
Fluoxetine in KCNC1-related Disorder
A Single Patient Trial of Fluoxetine in KCNC1-related Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Holland Bloorview Kids Rehabilitation Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single patient study of oral powdered fluoxetine to target developmental outcomes in a child with KCNC1-related disorder. This trial will be conducted at Holland Bloorview Kids Rehabilitation Hospital over 32 to 42 weeks, using a quasi experimental ABA phase design (placebo-fluoxetine-placebo) with randomized and blinded active treatment start and stop moments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluoxetine | Oral fluoxetine daily, 2.5 to 5 mg. |
Timeline
- Start date
- 2024-01-17
- Primary completion
- 2024-11-28
- Completion
- 2024-11-28
- First posted
- 2024-04-02
- Last updated
- 2025-07-02
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06341127. Inclusion in this directory is not an endorsement.